IndiaOne Finance - Company Dashboard

Governance Classic Home

Ambalal Sarabhai Enterprises LtdPharmaceuticalsINE432A01017Standalone₹40.45+0.58 (+1.45%)Jun-26

Valuation

Market Cap₹309.98 Cr

TTM PE74.91x

Forward PE51.42x

PEG0.71

Book Value₹18.27

P/B2.21x

TTM EPS₹0.54

Fwd EPS₹0.79

TTM Revenue₹2.85 Cr

TTM PAT₹3.10 Cr

TTM EBITDA₹-5.17 Cr

TTM EBIT₹-5.25 Cr

Last Qtr PAT₹0.03 Cr

Last Qtr EBITDA₹-1.23 Cr

Last Qtr EBIT₹-1.25 Cr

Profitability

ROE2.21%

ROCE2.00%

TTM NPM108.77%

TTM EBITDA %-181.40%

Curr OPM5.51%

Last OPM105.99%

Curr NPM—

Last NPM—

Curr EPS₹0.00

Last EPS₹0.35

Balance sheet

Equity₹76.63 Cr

Reserve₹63.34 Cr

Total Debt₹48.59 Cr

D/E0.35x

Interest %566.67%

Curr Interest₹0.17 Cr

Price / range

Close₹40.45

vs 52W High-19.07%

vs 52W Low+74.96%

MA50—

MA200—

Returns

1D+1.45%

1W-0.39%

1M-15.20%

3M+26.29%

6M+43.95%

1Y+30.78%

2Y-35.25%

3Y+11.83%

5Y+30.48%

Diwali+40.01%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	0.54-67.1%	1.52	0	0.79	1.64	3.94
Other Income	1.70	3.16	2.89	1.36	8.17	15.57
Total Income	2.24-77.2%	4.67	2.89	2.15	9.81	19.52
Interest	0.17	0.17	0.09	0.08	0.07	0.40
Expenditure	-1.96+32.4%	-3.06	-1.06	-2.53	-2.90	-9.57
PBDT	0	0	0	0	0	0
EBITDA	-1.23-5.1%	-1.35	-0.95	-1.64	-1.17	-5.13
Depreciation	-0.02	-0.02	-0.02	-0.02	-0.02	-0.10
EBIT	-1.25-5.0%	-1.37	-0.97	-1.66	-1.19	-5.23
PBT	0.29-95.8%	1.61	1.83	-0.38	6.89	9.95
Tax	-0.26	1.04	0.01	0	0	1.04
Equity	0	0	0	0	0	0
OPM	52.57	105.99	0.00	-48.16	421.09	51.00
Net Profit	0.03-99.6%	1.61	1.84	-0.38	6.88	10.99
NPM	5.51	105.99	0.00	-48.42	420.78	56.00
EPS	0	0.35	0.24	-0.05	0	1.43

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	3.94-2.5%	4.04+6.0%	3.81+2.7%	3.71+2753.8%	0.13	0
Other Income	15.57	15.29	7.89	10.53	39.54	29.61
Total Income	19.52+1.0%	19.33+65.2%	11.70-17.8%	14.24-64.1%	39.66+33.9%	29.61
Expenditure	-9.57+19.0%	-11.81-8.4%	-10.89-19.4%	-9.12-48.8%	-6.13+84.3%	-39.08
Interest	-0.40	-0.34	-0.19	-0.11	-0.25	-0.56
PBDT	0	0	0	0	0	0
EBITDA	-5.13+30.0%	-7.33-8.3%	-6.77-31.5%	-5.15+7.4%	-5.56+85.4%	-38.14
Depreciation	-0.10	-0.10	-0.12	-0.15	-0.19	-0.38
EBIT	-5.23+29.6%	-7.43-7.8%	-6.89-30.0%	-5.30+7.8%	-5.75+85.1%	-38.52
PBT	9.95+23.1%	8.08+885.4%	0.82-81.1%	4.34+25.8%	3.45+136.4%	-9.47
Tax	1.04	0.16	1.77	-0.23	-0.50	0.08
Equity	0	76.63	0	0	0	0
OPM (%)	51.00	41.78	7.00	30.00	9.00	-32.00
Net Profit	10.99+33.4%	8.24+219.4%	2.58-37.2%	4.11+38.9%	2.96+131.5%	-9.39
NPM (%)	56.00	42.63	22.00	29.00	7.00	-32.00
EPS (Rs)	1.43+32.4%	1.08+217.6%	0.34-37.0%	0.54+38.5%	0.39+132.0%	-1.22
CEPS	1.43	1.08	0.34	0.54	0.39	-1.22

Metric	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	FY24-25
Revenue	52+13.1%	44.45	40.34	64.81	45.97	196.19
Other Income	2.58	1.62	8.36	1.63	5.61	11.38
Total Income	54.58+5.8%	46.07	48.70	66.45	51.58	207.57
Interest	0	0.96	1.01	0.96	1.14	4.26
Expenditure	-49.58-1.6%	-45.96	-40.70	-61.30	-48.80	-196.38
PBDT	0	0	0	0	0	0
EBITDA	2.42+445.7%	0.51	1.53	5.49	-0.70	8.08
Depreciation	0	-1.06	-0.88	-1.02	-0.99	-4.01
EBIT	2.42+243.2%	-0.55	0.65	4.47	-1.69	4.07
PBT	4.18+50.4%	0.11	7.95	0	2.78	4.19
Tax	-0.72	-0.52	0.20	1.70	-0.70	0.10
Equity	0	0	0	0	0	76.63
OPM	7.66	0.25	16.33	0.00	5.39	2.02
Net Profit	3.64+63.2%	-0.56	8.22	-0.27	2.23	4.93
NPM	6.67	-1.22	16.89	-0.40	4.33	2.38
EPS	0-100.0%	-0.07	1.07	-0.04	0.29	0.64

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21	FY 19-20
Revenue	196.19+13.0%	173.57+1.9%	170.28-13.5%	196.75+20.2%	163.64+22.6%	133.50
Other Income	11.38	10.38	12.49	42.02	30.58	24.39
Total Income	207.57+12.8%	183.95+0.6%	182.77-23.5%	238.76+22.9%	194.22+23.0%	157.89
Expenditure	-196.38-12.5%	-174.58-4.6%	-166.91+5.1%	-175.88-3.0%	-170.79-20.6%	-141.58
Interest	-4.26	-3.76	-2.44	-1.70	-2.95	-3.32
PBDT	0	0	0	0	0	0
EBITDA	8.08+27.6%	6.33-26.1%	8.57-65.6%	24.89+1490.5%	-1.79+18.3%	-2.19
Depreciation	-4.01	-3.58	-2.76	-2.32	-2.41	-2.57
EBIT	4.07+48.0%	2.75-52.7%	5.81-74.3%	22.57+637.4%	-4.20+11.8%	-4.76
PBT	4.19-55.2%	9.36-41.0%	15.87-66.8%	47.77+103.9%	23.43+43.7%	16.31
Tax	0.10	-0.97	-3.72	-6.98	-3.19	-0.88
Equity	76.63	0	0	0	0	0
OPM (%)	2.02	5.09	8.68	20.01	12.06	10.33
Net Profit	4.93-13.2%	5.68-48.8%	11.10-76.5%	47.22+60.9%	29.35+108.7%	14.06
NPM (%)	2.38	3.09	6.07	19.78	15.11	8.90
EPS (Rs)	0.64-13.5%	0.74-49.0%	1.45-76.5%	6.16+60.8%	3.83+109.3%	1.83
CEPS	0.64	0.74	1.45	6.16	3.83	1.83

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split